CY2141B1 - 1,2,3,4-Tetrahydronaphthalene chroman and thiochroman derivatives as antithrombotic agents - Google Patents
1,2,3,4-Tetrahydronaphthalene chroman and thiochroman derivatives as antithrombotic agentsInfo
- Publication number
- CY2141B1 CY2141B1 CY9900037A CY9900037A CY2141B1 CY 2141 B1 CY2141 B1 CY 2141B1 CY 9900037 A CY9900037 A CY 9900037A CY 9900037 A CY9900037 A CY 9900037A CY 2141 B1 CY2141 B1 CY 2141B1
- Authority
- CY
- Cyprus
- Prior art keywords
- substituted
- unsubstituted
- chroman
- tetrahydronaphthalene
- group
- Prior art date
Links
- OLAKECXZUBSTCA-UHFFFAOYSA-N 3,4-dihydro-2H-chromene 1,2,3,4-tetrahydronaphthalene Chemical compound O1CCCC2=CC=CC=C12.C1CCCC2=CC=CC=C12 OLAKECXZUBSTCA-UHFFFAOYSA-N 0.000 title 1
- WPWNEKFMGCWNPR-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromene Chemical class C1=CC=C2CCCSC2=C1 WPWNEKFMGCWNPR-UHFFFAOYSA-N 0.000 title 1
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229960004676 antithrombotic agent Drugs 0.000 title 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- -1 imidazolylmethyl Chemical group 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 229910052760 oxygen Chemical group 0.000 abstract 1
- 239000001301 oxygen Chemical group 0.000 abstract 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000005302 thiazolylmethyl group Chemical group [H]C1=C([H])N=C(S1)C([H])([H])* 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312237A FR2711139B1 (fr) | 1993-10-15 | 1993-10-15 | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2141B1 true CY2141B1 (en) | 2002-06-21 |
Family
ID=9451827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY9900037A CY2141B1 (en) | 1993-10-15 | 1999-11-19 | 1,2,3,4-Tetrahydronaphthalene chroman and thiochroman derivatives as antithrombotic agents |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5472979A (el) |
| EP (1) | EP0648741B1 (el) |
| JP (1) | JP2859138B2 (el) |
| AT (1) | ATE146454T1 (el) |
| AU (1) | AU676377B2 (el) |
| CA (1) | CA2118102C (el) |
| CY (1) | CY2141B1 (el) |
| DE (1) | DE69401190T2 (el) |
| DK (1) | DK0648741T3 (el) |
| ES (1) | ES2098109T3 (el) |
| FR (1) | FR2711139B1 (el) |
| GR (1) | GR3022637T3 (el) |
| HK (1) | HK64397A (el) |
| NZ (1) | NZ264703A (el) |
| ZA (1) | ZA948082B (el) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9509156D0 (en) * | 1995-05-05 | 1995-06-28 | Sandoz Ltd | Organic compounds |
| DE19647000A1 (de) * | 1996-11-14 | 1998-05-20 | Hoechst Ag | 3-Amido-chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| FR2760235B1 (fr) * | 1997-02-28 | 1999-04-09 | Adir | Nouveaux derives de benzenesulfonylamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2803848B1 (fr) * | 2000-01-19 | 2002-02-15 | Adir | Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP4490543B2 (ja) * | 2000-03-07 | 2010-06-30 | 日本曹達株式会社 | α−アミノケトン類の製造方法 |
| FR2838057B1 (fr) * | 2002-04-05 | 2005-07-08 | Servier Lab | Nouvelle association d'un antithrombotique et d'aspirine |
| FR2857593B1 (fr) * | 2003-07-18 | 2005-10-14 | Servier Lab | Composition pharmaceutique orodispersible d'un compose antithrombotique |
| FR2860436B1 (fr) * | 2003-10-03 | 2006-01-20 | Servier Lab | Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire |
| FR2899473B1 (fr) | 2006-04-07 | 2008-06-13 | Servier Lab | Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires |
| FR2920772B1 (fr) | 2007-09-11 | 2009-10-23 | Servier Lab | Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine |
| EP2098511A1 (en) | 2008-03-07 | 2009-09-09 | Solvias AG | Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| US20130190370A1 (en) * | 2010-07-29 | 2013-07-25 | The Trustees Of The University Of Pennsylvania | Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor |
| CN103102292B (zh) * | 2011-11-14 | 2015-05-20 | 上海医药工业研究院 | 一种快速无污染由伯醇氧化为醛的方法 |
| WO2014165633A1 (en) * | 2013-04-04 | 2014-10-09 | The Trustees Of The University Of Pennsylavania | Cycloakyl-dione derivatives and methods of their use |
| CN108707115B (zh) * | 2018-07-17 | 2020-09-01 | 成都道合尔医药技术有限公司 | 一种丙烯酸衍生物的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| DE3623941A1 (de) * | 1986-07-16 | 1988-01-28 | Bayer Ag | Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel |
| US5206428A (en) * | 1989-11-16 | 1993-04-27 | Tanabe Seiyaku Co., Ltd. | Tetrahydronaphthalene derivatives and preparation thereof |
| JPH05178814A (ja) * | 1991-05-14 | 1993-07-20 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
-
1993
- 1993-10-15 FR FR9312237A patent/FR2711139B1/fr not_active Expired - Fee Related
-
1994
- 1994-10-13 DK DK94402299.5T patent/DK0648741T3/da active
- 1994-10-13 AU AU75820/94A patent/AU676377B2/en not_active Ceased
- 1994-10-13 EP EP94402299A patent/EP0648741B1/fr not_active Expired - Lifetime
- 1994-10-13 ES ES94402299T patent/ES2098109T3/es not_active Expired - Lifetime
- 1994-10-13 AT AT94402299T patent/ATE146454T1/de active
- 1994-10-13 DE DE69401190T patent/DE69401190T2/de not_active Expired - Lifetime
- 1994-10-13 CA CA002118102A patent/CA2118102C/fr not_active Expired - Fee Related
- 1994-10-14 NZ NZ264703A patent/NZ264703A/en not_active IP Right Cessation
- 1994-10-14 US US08/323,508 patent/US5472979A/en not_active Expired - Lifetime
- 1994-10-14 JP JP6249589A patent/JP2859138B2/ja not_active Expired - Fee Related
- 1994-10-14 ZA ZA948082A patent/ZA948082B/xx unknown
-
1997
- 1997-02-21 GR GR970400323T patent/GR3022637T3/el unknown
- 1997-05-15 HK HK64397A patent/HK64397A/xx not_active IP Right Cessation
-
1999
- 1999-11-19 CY CY9900037A patent/CY2141B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK64397A (en) | 1997-05-23 |
| CA2118102A1 (fr) | 1995-04-16 |
| JPH07188155A (ja) | 1995-07-25 |
| NZ264703A (en) | 1995-09-26 |
| DE69401190D1 (de) | 1997-01-30 |
| US5472979A (en) | 1995-12-05 |
| GR3022637T3 (en) | 1997-05-31 |
| AU676377B2 (en) | 1997-03-06 |
| FR2711139B1 (fr) | 1995-12-01 |
| ZA948082B (en) | 1995-06-05 |
| DK0648741T3 (da) | 1997-06-09 |
| EP0648741A1 (fr) | 1995-04-19 |
| ES2098109T3 (es) | 1997-04-16 |
| JP2859138B2 (ja) | 1999-02-17 |
| AU7582094A (en) | 1995-05-11 |
| DE69401190T2 (de) | 1997-07-03 |
| FR2711139A1 (fr) | 1995-04-21 |
| ATE146454T1 (de) | 1997-01-15 |
| EP0648741B1 (fr) | 1996-12-18 |
| CA2118102C (fr) | 2000-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2141B1 (en) | 1,2,3,4-Tetrahydronaphthalene chroman and thiochroman derivatives as antithrombotic agents | |
| AU680704B2 (en) | Cyclic amide derivatives | |
| HK1026700A1 (en) | 1,4-Substituted cyclic amine derivatives or dihydroindole derivatives and medicament thereof. | |
| MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
| KR920004341A (ko) | 술폰아미드 유도체 | |
| IE792074L (en) | Pyran- and thiopyran-fused heterocyclic compounds | |
| HK1030413A1 (en) | Aryloxyaniline derivatives | |
| AU7137491A (en) | New aminomethylpiperidine derivatives, process for preparing these and pharmaceutical compositions containing them | |
| AU2044697A (en) | Phenylalkylcarboxylic acid derivatives | |
| AU3381389A (en) | Derivative of caffeic acid and pharmaceutical composition containing the same | |
| ATE118770T1 (de) | Thiazolidinone und oxazolidenonederivate, ihre herstellung und ihre anwendung als vasodilatatoren. | |
| IE892294L (en) | Cycloalkylthiazole derivatives | |
| AU1424795A (en) | Indole derivative | |
| AU5891586A (en) | 17 - spartein derivatives | |
| AU624724B2 (en) | Pyrrolo(2,1-b)thiazole derivatives | |
| AU6426386A (en) | Derivatives of 3-imino-pyridazine, process for obtaining them and pharmaceutical compositions containing them |